Influence of fusaric acid on urinary excretion of catecholamines: a clinical study with particular emphasis on the characteristics of its time-course change.
D000284:Administration, Oral; D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000652:urine*; D002845:Chromatography; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D004837:Epinephrine / Q000652:urine; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology / Q000652:urine; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D010848:Picolinic Acids / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D012110:Reserpine / Q000494:pharmacology / Q000627:therapeutic use; D013053:Spectrophotometry; D013997:Time Factors
D000959:Antihypertensive Agents; D002395:Catecholamines; D010848:Picolinic Acids; D012110:Reserpine; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine; D004837:Epinephrine